Abby Kennedy

Abby Kennedy currently serves as the Vice President of Clinical Operations at Jasper Therapeutics since April 2025. Prior to this role, Abby held the position of Senior Vice President of Clinical Operations at DermBiont, Inc. from July 2024 to April 2025 and was Vice President of Clinical Operations at CymaBay Therapeutics from March 2021 to July 2024. Previous experience includes serving as Senior Director of Clinical Operations at Principia Biopharma, Senior Clinical Program Leader at Genentech, and various roles at XOMA and Exelixis, including Sr. Manager of Clinical Operations. Abby has a robust academic background, holding a PhD in Organic Chemistry from the University of Arizona and a BS in Chemistry from Allegheny College, with additional certification in Clinical Trial Design & Management from San Francisco State University. Abby also served as Chair of the American Chemical Society from 2010 to 2011, showcasing leadership in the field.